In Unstable Angina or Non–ST-Segment Acute Coronary Syndrome, Should Patients With Multivessel Coronary Artery Disease Undergo Multivessel or Culprit-Only Stenting?
Mehdi H. Shishehbor, DO, MPH*,1,
Michael S. Lauer, MD, FACC*,
Inder M. Singh, MD, MS ,
Derek P. Chew, MBBS, MPH ,
Juhana Karha, MD*,
Sorin J. Brener, MD, FACC*,
David J. Moliterno, MD, FACC ,2,
Stephen G. Ellis, MD, FACC*,
Eric J. Topol, MD, FACC|| and
Deepak L. Bhatt, MD, FACC*,3,*
* Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio
Department of Cardiology, Flinders Medical Center, South Australia, Australia
Gill Heart Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky
|| Department of Genetics, Case Western Reserve University, Cleveland, Ohio
View larger version (20K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Kaplan-Meier Curves for Patients Undergoing Multivessel Versus Culprit-Only Stenting
(A) Kaplan-Meier curves for the composite end point of death, myocardial infarction (MI), or revascularization for patients undergoing multivessel versus culprit-only stenting (n = 1,240). (B) Kaplan-Meier curves for the composite end point of death or MI for patients undergoing multivessel versus culprit-only stenting (n = 1,240). (C) Kaplan-Meier mortality curves for patients undergoing multivessel versus culprit-only stenting (n = 1,240). (D) Kaplan-Meier curves for revascularization for patients undergoing multivessel versus culprit-only stenting (n = 1,240).
|
|
View larger version (21K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Kaplan-Meier Curves for Propensity-Matched Patients Undergoing Multivessel Versus Culprit-Only Stenting
(A) Kaplan-Meier curves for the composite end point of death, myocardial infarction (MI), or revascularization for propensity-matched patients undergoing multivessel versus culprit-only stenting (n = 630). (B) Kaplan-Meier curves for the composite end point of death or MI for propensity-matched patients undergoing multivessel versus culprit-only stenting (n = 630). (C) Kaplan-Meier mortality curves for propensity-matched patients undergoing multivessel versus culprit-only stenting (n = 630). (D) Kaplan-Meier curves for revascularization for propensity-matched patients undergoing multivessel versus culprit-only stenting (n = 630).
|
|
|
